Skip to main content
Clinical Trials/NCT04424797
NCT04424797UnknownNot Applicable

Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol

Poudre Valley Health System3 sites in 1 country100 target enrollmentStarted: July 13, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
100
Locations
3
Primary Endpoint
Incidence of intubation

Study Overview

Brief Summary

A pilot study to investigate the effects of the prone positioning (PP) on hospital patients diagnosed with COVID-19 pneumonia.

Investigators that early self-proning may prevent intubation and improve mortality in patients with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2).

Up to 100 participants with a primary diagnosis of confirmed COVID-19 pneumonia will be enrolled to the study.

All participants will be screened and those that meet inclusion and exclusion criteria will be enrolled to one of two groups: one with prone positioning (on the belly) and the other with standard supine positioning (on the back). The patient and nursing staff will monitor times spent in various positions.

Outcome measures include incidence of intubation, max oxygen requirements, length of hospital stay, ventilator-free days, worsening of oxygenation saturation, and mortality.

Detailed Description

In hypoxic respiratory failure, placing patients in the prone position improves ventilation to perfusion matching, alveolar recruitment, and alveolar to arterial oxygen gradients. Specifically, in Acute Respiratory Distress Syndrome ARDS, proning intubated patients improves overall mortality. With the emergence of SARS-COV-2, hospitals around the world have seen a marked increase in patients with acute hypoxic respiratory failure and ARDS. This surge in cases has prompted a search for more effective strategies to reduce intubation and improve patient morbidity and mortality. One such strategy is that of voluntary proning, in which awake patients are instructed to prone themselves (Early PP With High Flow Nasal Cannula (HFNC) Versus HFNC in COVID-19 Induced Moderate to Severe ARDS) (COVID-19 smArtphone-based Trial of Non-ICU Admission Prone Positioning (CATNAP)).

This trial proposes a voluntary proning strategy in patients admitted to the hospital, not yet requiring mechanical ventilation. Given the clear evidence that proning improves outcomes in ARDS, investigators hypothesize that early, voluntary self-proning may prevent intubation and improve mortality in patients with SARS-COV-2.

Methods

This is a pilot study of up to 100 participants at UCHealth facilities.

Patients will be assessed if they can self prone safely and be assessed against inclusion and exclusion criteria within 12 hours of admission and randomized to either prone or supine positioning. Baseline labs will be measured and all participants will be monitored continuously via pulse oximetry.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients admitted to the hospital floor with primary diagnosis of confirmed COVID-19 pneumonia and respiratory failure requiring greater than or equal to 2 Liters(L) Nasal Cannula (NC) to maintain SpO2>90%
  • •Ability to independently change positions in bed
  • •Able to tolerate prone positioning
  • •Age greater than 18

Exclusion Criteria

  • •ICU admission on arrival
  • •Respiratory distress requiring immediate intubation
  • •Respiratory Rate(RR)>35/min, accessory respiratory muscle use (ex. speaking in short sentences), signs of respiratory muscle fatigue, altered mental status, or inability to protect airway
  • •Chest or facial trauma, pneumothorax or other contraindication to prone positioning (i.e., spinal instability, recent abdominal surgery, pregnancy, etc)
  • •Hemodynamically unstable
  • •Heart Rate (HR)>120 bpm, Systolic Blood Pressure (SBP)<90 mmHg, Mean Arterial Pressure (MAP)<65 mmHg or requirement for vasopressor
  • •Nausea and vomiting
  • •Pregnancy
  • •Refusal or inability to tolerate initial prone positioning due to comfort

Arms & Interventions

Prone Positioning

Experimental

Prone positioning

Intervention: Prone Positioning (Other)

Supine Positioning

Other

Supine Positioning

Intervention: Supine Positioning (Other)

Outcomes

Primary Outcomes

Incidence of intubation

Time Frame: Through study completion, an average of 6 days

Incidence of intubation

Secondary Outcomes

  • Mortality(Through study completion, an average of 6 days)
  • Ventilator-free days(Through study completion, an average of 6 days)
  • Treatment failure of prone positioning due to worsening SpO2 status while prone(Through study completion, an average of 6 days)
  • Maximum oxygen requirement(Through study completion, an average of 6 days)
  • Length of Stay(Through study completion, an average of 6 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Lucie Uncapher

Investigator

Poudre Valley Health System

Study Sites (3)

Loading locations...

Similar Trials